共 462 条
[1]
Stone NJ(2014)2013 ACC/AHA guideline on the treatment of blood cholesterol to reduce atherosclerotic cardiovascular risk in adults: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines Circulation 129 S1-45
[2]
Robinson JG(2016)European guidelines on cardiovascular disease prevention in clinical practice Eur J Prev Cardiol 23 Np1-np96-2472
[3]
Lichtenstein AH(2017)Low-density lipoproteins cause atherosclerotic cardiovascular disease. 1. Evidence from genetic, epidemiologic, and clinical studies. A consensus statement from the European Atherosclerosis Society Consensus Panel Eur Heart J 38 2459-307
[4]
Bairey Merz CN(2017)Remnant lipoproteins Curr Opin Lipidol 28 300-1942
[5]
Blum CB(2017)HDL cholesterol metabolism and the risk of CHD: new insights from human genetics Curr Cardiol Rep 19 132-1931
[6]
Eckel RH(2017)Evacetrapib and cardiovascular outcomes in high-risk vascular disease N Engl J Med 376 1933-2043
[7]
Goldberg AC(2017)Very low LDL-cholesterol concentrations achieved: which target is next? Lancet 390 1930-1722
[8]
Gordon D(2016)Blood pressure and cholesterol lowering in persons without cardiovascular disease N Engl J Med 374 2032-436
[9]
Levy D(2017)Evolocumab and clinical outcomes in patients with cardiovascular disease N Engl J Med 376 1713-635
[10]
Lloyd-Jones DM(2013)Remnant cholesterol as a causal risk factor for ischemic heart disease J Am Coll Cardiol 61 427-193